Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
We are building an AI-native operating system for pharma sales and distribution
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Shashwat Goenka takes over as Vice President of industry body
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Subscribe To Our Newsletter & Stay Updated